ArticleHuman vaccines & immunotherapeutics2021
The demand for a COVID-19 vaccine in Kenya.
Article in Human vaccines & immunotherapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it.
- COVID-19 vaccine acceptance and associated factors in 13 African countries: A systematic review and meta-analysis.Frontiers in public health · 2022Pooled it
- Scoping review of COVID-19 vaccines access, equity, hesitancy, and uptake in Kenya: lessons for the next pandemic.Frontiers in health services · 2026Review
- SARS-CoV-2 vaccine uptake, knowledge and attitude among health workers in Nairobi, Kenya: a quantitative study.Frontiers in public health · 2026Article
- Review
- Determinants of COVID-19 vaccine hesitancy among healthcare personnel in a secondary-level health facility in Ghana.PLOS global public health · 2025Article
- Cost-based COVID-19 vaccination and willingness to pay: A post-pandemic review.Human vaccines & immunotherapeutics · 2024Review
- Willingness to pay for a COVID-19 vaccine and its associated determinants in Iran.Frontiers in public health · 2023Article
- Review
- COVID-19 vaccine hesitancy in Africa: a scoping review.Global health research and policy · 2022Article
- Financing COVID-19 vaccination in sub-Saharan Africa: lessons from a nation-wide willingness to pay (WTP) survey in Ghana.BMC public health · 2022Article
- Article
- COVID-19 Vaccine Acceptance among Low- and Lower-Middle-Income Countries: A Rapid Systematic Review and Meta-Analysis.Vaccines · 2022Review
- Predictors of COVID-19 Vaccine Hesitancy in South African Local Communities: The VaxScenes Study.Vaccines · 2022Article
- Black People Narrate Inequalities in Healthcare Systems that Hinder COVID-19 Vaccination: Evidence from the USA and the UK.Journal of African American studies (New Brunswick, N.J.) · 2022Article
- Health-care Workers' Willingness to Pay for COVID-19 Vaccines in Eastern Ethiopia: Using Contingent Valuation Method.ClinicoEconomics and outcomes research : CEOR · 2022Article
- Application of bioreactor technology for cell culture-based viral vaccine production: Present status and future prospects.Frontiers in bioengineering and biotechnology · 2022Review
- Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China.Frontiers in pharmacology · 2022Article
- On willingness to pay for Covid-19 vaccines: a case study from India.Human vaccines & immunotherapeutics · 2021Article
- COVID-19 Vaccine Demand and Financial Incentives.Applied health economics and health policy · 2021Article
- Covid-19 Vaccine Acceptance and Determinant Factors among General Public in East Africa: A Systematic Review and Meta-Analysis.Health services research and managerial epidemiologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The goal of achieving herd immunity to the coronavirus requires high vaccination acceptance levels on the part of the population. The objectives of this study were to: 1) Measure individuals' willingness to pay (WTP) for a COVID-19 vaccine in Kenya; 2) evaluate the effect of vaccine characteristics (duration of protection and efficacy) and individuals' socioeconomic variables on WTP, and 3) estimate the aggregate demand and economic value of a COVID-19 vaccine. The contingent valuation (CV) method was used as the basis for the analyses. Data for this study were obtained from a survey of 1,050 individuals in Kenya conducted from April 7 to April 15, 2020. The survey included CV questions using a double-bounded dichotomous choice format. Results reveal that most of the individuals in Kenya (at least 96%) were willing to accept a COVID-19 vaccine. Approximately 80% of individuals were willing to pay a positive amount. Conservative estimates of individuals' mean WTP for the vaccine range from USD 49.81 to USD 68.25 (depending on vaccine characteristics). Both vaccine duration of protection and efficacy were found to influence WTP (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.